Sound Income Strategies’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Sound Income Strategies’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-350	Closed	-$445	–	1417
2023 Q3	$445	Hold	350	–	–	﹤0.01%	1075
2023 Q2	$114	Hold	350	–	–	﹤0.01%	1077
2023 Q1	$151	Hold	350	–	–	﹤0.01%	1037
2022 Q4	$186	Hold	350	–	–	﹤0.01%	960
2022 Q3	$0	Hold	350	–	–	﹤0.01%	1004
2022 Q2	$0	Hold	350	–	–	﹤0.01%	968
2022 Q1	$1K	Hold	350	–	–	﹤0.01%	860
2021 Q4	$1K	Hold	350	–	–	﹤0.01%	828
2021 Q3	$1K	Hold	350	–	–	﹤0.01%	808
2021 Q2	$2K	Hold	350	–	–	﹤0.01%	758
2021 Q1	$1.63K	Hold	350	–	–	﹤0.01%	789
2020 Q4	$1K	Hold	350	–	–	﹤0.01%	849
2020 Q3	$1K	Hold	350	–	–	﹤0.01%	814
2020 Q2	$1K	Hold	350	–	–	﹤0.01%	755
2020 Q1	$1K	Hold	350	–	–	﹤0.01%	728
2019 Q4	$2K	Hold	350	–	–	﹤0.01%	593
2019 Q3	$3K	Hold	350	–	–	﹤0.01%	515
2019 Q2	$5K	Hold	350	–	–	﹤0.01%	453
2019 Q1	$2K	Buy	+350	New	+$1.7K	﹤0.01%	574

Sound Income Strategies's ZYNE Position: Q4 2023 in Review

Sound Income Strategies sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 350 shares — an estimated $445 sold.

Sound Income Strategies first reported a position in ZYNE in Q1 2019 and held it in 19 quarters. The position peaked at $5K in Q2 2019. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

Sound Income Strategies reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
Sound Income Strategies sold 350 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $445.
Sound Income Strategies first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2019 and held it in 19 quarters.
Sound Income Strategies's Zynerba Pharmaceuticals, Inc position peaked at $5K in Q2 2019.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Sound Income Strategies's 13F filing for Q4 2023, filed 10 Jan 2024.